B. Braun Medical Inc. has initiated a voluntary nationwide recall of three lots of its 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container. The recall, announced on August 19, 2026, is due to the presence of particulate matter identified as zinc oxide within the product.
The administration of the affected injection has a reasonable probability of causing life-threatening adverse health consequences. These risks include pulmonary emboli, occlusions of other blood vessels leading to tissue death and organ damage, and phlebitis.
Furthermore, foreign particles infused intravenously can cause systemic activation of the immune system, organ dysfunction, and hemolysis. To date, there have been no reports of serious injury, death, or other adverse events associated with this issue.